AdvaMed09.21.20
The Advanced Medical Technology Association (AdvaMed) and StartX have entered a partnership designed to provide medtech entrepreneurs within the StartX network exclusive access to AdvaMed’s resources and expertise to develop and commercialize the latest health care innovations.
This partnership brings together AdvaMed, a trade association for medical technology manufacturers and innovators, and StartX, a startup community for entrepreneurs affiliated with Stanford University. StartX’s medical community consists of more than 450+ entrepreneurs, managing more than 180 active companies developing transformative medical devices, diagnostic tests, patient monitoring systems, devices to support cancer care and drug-device combinations. They include Stanford professors, first-time entrepreneurs who have raised hundreds of millions, and seasoned entrepreneurs with multiple successes.
StartX Med entrepreneurs are invited to join AdvaMed’s CEO and executive-led community of large medtech and diagnostics companies and nearly 300 smaller, start-up and early-stage companies in the AdvaMed Accel division. In addition, AdvaMedDx and the association’s Center for Digital Health provide focused efforts and resources now available to StartX Med companies in the diagnostics and digital health fields.
“StartX Med has done a remarkable job of advancing incredible innovations that save and improve lives. I’m really excited about this partnership, which gives us, working together, the opportunity to get more of those innovations into doctors’ and patients’ hands,” said Scott Whitaker, AdvaMed president and CEO. “And through AdvaMed Accel, StartX Med alumni will have access to essential resources, decision makers, and information critical to bringing their life-saving and life-changing innovations to patients.”
"It is with open arms that we welcome AdvaMed as a partner to strengthen the support we are providing to our founders innovating in the biomedical fields,” shared Joseph Huang, StartX CEO. “Our community represents the best and brightest founders from Stanford and around the world, including more than 60 tenure-track Stanford Professors translating their research all the way to impacting real patients. With this partnership with AdvaMed, we are sure to improve the time in which it takes these transformative products to reach patients and clinical care worldwide.”
This partnership brings together AdvaMed, a trade association for medical technology manufacturers and innovators, and StartX, a startup community for entrepreneurs affiliated with Stanford University. StartX’s medical community consists of more than 450+ entrepreneurs, managing more than 180 active companies developing transformative medical devices, diagnostic tests, patient monitoring systems, devices to support cancer care and drug-device combinations. They include Stanford professors, first-time entrepreneurs who have raised hundreds of millions, and seasoned entrepreneurs with multiple successes.
StartX Med entrepreneurs are invited to join AdvaMed’s CEO and executive-led community of large medtech and diagnostics companies and nearly 300 smaller, start-up and early-stage companies in the AdvaMed Accel division. In addition, AdvaMedDx and the association’s Center for Digital Health provide focused efforts and resources now available to StartX Med companies in the diagnostics and digital health fields.
“StartX Med has done a remarkable job of advancing incredible innovations that save and improve lives. I’m really excited about this partnership, which gives us, working together, the opportunity to get more of those innovations into doctors’ and patients’ hands,” said Scott Whitaker, AdvaMed president and CEO. “And through AdvaMed Accel, StartX Med alumni will have access to essential resources, decision makers, and information critical to bringing their life-saving and life-changing innovations to patients.”
"It is with open arms that we welcome AdvaMed as a partner to strengthen the support we are providing to our founders innovating in the biomedical fields,” shared Joseph Huang, StartX CEO. “Our community represents the best and brightest founders from Stanford and around the world, including more than 60 tenure-track Stanford Professors translating their research all the way to impacting real patients. With this partnership with AdvaMed, we are sure to improve the time in which it takes these transformative products to reach patients and clinical care worldwide.”
